Hydropower has been around for more than a century, and is currently the nation’s largest source of clean, domestic, renewable electricity. What could its role look like in the year 2050?
Providing about 7 percent of the nation’s electricity, hydropower supports more than 143, 000 jobs in engineering, manufacturing, construction and utility operations and maintenance — all while improving the environment and strengthening our economy. Additionally, pumped-storage hydropower represents 97 percent of all energy storage in the United States, offering the flexibility and reliability the electricity grid needs to deliver affordable clean energy to American homes and businesses.
So what does the future of hydropower look like? To answer that question, over the past two years the Energy Department has collaborated with more than 300 experts from more than 150 hydropower industry companies, environmental organizations, state and federal governmental agencies, academic institutions, electric power system operators, research institutions and other stakeholders to explore how it could evolve in the coming decades.
Germany-based Peri isn’t a newcomer to the ever-growing 3Dconstruction printing segment. The apartment building is currently being printed in Bavaria, Germany, and the project was unveiled only two months after Peri announced i t was creating Germany’s first 3D printed two-story detached home.
Unlike the first project, this upcoming three-floor apartment building will contain 4, 090 square feet of occupiable space in the form of five apartment units and a basement. The units will be available in different sizes, good for both single occupants and families, Peri’s global business development manager of 3D construction printing Jan Graumann told Business Insider in an email interview.
The first step is to understand qubits and superposition. The next one is to get a handle on the business advantage that this technology represents.
If “figure out quantum computing” is still in your future file, it’s time to update your timeline. The industry is nearing the end of the early adopter phase, according to one expert, and the time is now to get up to speed.
Denise Ruffner, the vice president of business development at IonQ, said that quantum computing is evolving much faster than many people realize.
Yuri Deigin, MBA is a serial biotech entrepreneur, longevity research evangelist and activist, and a cryonics advocate. He is an expert in drug development and venture investments in biotechnology and pharmaceuticals. He is the CEO at Youthereum Genetics and the Vice President at Science for Life Extension Research Support Foundation. http://youthereum.ca/
Yuri has a track record of not only raising over $20 million for his previous ventures but also initiating and overseeing 4 clinical trials and several preclinical studies, including studies in transgenic mice.
At Youthereum Genetics, Yuri is currently leading a project dedicated to developing an epigenetic rejuvenation gene therapy, as intermittent epigenetic partial reprogramming demonstrated great experimental results in mice: it extended their lifespan by up to 50%.
His life goal is to do everything possible to minimize human suffering from various diseases, especially terminal age-related diseases such as cancer, Alzheimer’s, and cardiovascular disease and to help humanity eradicate them. As an activist, blogger, and speaker, he is conveying the magnitude of human suffering these diseases cause, as they take over 100,000 lives each day. As a biotech entrepreneur, Yuri is doing his modest part by putting together projects that could yield such therapies, splitting his time between Toronto and Moscow.
He believes that one day humanity will cure all such diseases, and he wants to do whatever he can to hasten that day.
Since 2013, Yuri also serves as the Vice President of the nonprofit Foundation, Science for Life Extension, whose goal is the popularization of the fight against age-related diseases. To further this cause, Yuri frequently blogs, speaks, writes op-ed pieces, and participates in various TV and radio shows. At the Science for Life Extension Foundation, Yuri is helping the Foundation create and implement social change strategies to create public awareness that aging is a curable disease. He is also working on initiating intergovernmental dialog and public hearings about including aging in WHO’s ICD-11.
Previously, Yuri was the COO and Managing Director at Pharma Bio in Moscow for almost 7 years. From 2015 to 2017, Yuri was the Vice President of Business Development at Manus Pharmaceuticals in Toronto, Canada where he worked on raising funding and forming strategic partnerships to develop breakthrough peptide compounds aimed at preventing Alzheimer’s disease. Before that, he was the VP of Business Development at Peptos Pharma in Moscow.
Dr. James Weinstein, is Senior Vice President, Microsoft Healthcare, where he is in charge of leading strategy, innovation and health equity functions.
Prior to Microsoft, Dr. Weinstein was president and CEO of Dartmouth-Hitchcock Health, a $2.0 billion academic medical center in Northern New England, where he led the organization to adopt a population health model, including the transition from fee-for-service toward global payments.
Prior to becoming CEO, Dr. Weinstein served as president of Dartmouth-Hitchcock Clinic and was director of The Dartmouth Institute for Health Policy and Clinical Practice (TDI), home of the Dartmouth Atlas of Health Care, which for decades has documented the ongoing variations in health care delivery across the United States.
Dr. Weinstein is a founding member and the inaugural executive director of the National High Value Healthcare Collaborative, along with Mayo Clinic, Intermountain Healthcare, The Dartmouth Institute, and Denver Health. The Collaborative is a partnership of health systems that has taken on the challenge of improving the quality of care while lowering costs on a national scale.
Dr. Weinstein is a member of the National Academies of Sciences, Engineering, and Medicine and held the Peggy Y. Thomson Chair in the Evaluative Clinical Sciences at the Geisel School of Medicine while at Dartmouth; he’s a Senior Fellow, for the Healthcare Center and Clinical Professor Tuck School of Business at Dartmouth and a Clinical Professor at the Kellogg School of Business, Northwestern University.
Dr. Weinstein is a member of Special Medical Advisory Group for the national Veteran’s Administration. He serves on the Boards of Trustees for the Max Planck Florida Institute for Neuroscience, the Intermountain Health System, and IMAGINECARE, a company he started while CEO to use remote sensing to manage patients outside the traditional brick-and-mortar medical system and serves on several other boards.
Throughout his career as a researcher and renowned spine surgeon, Dr. Weinstein has received more than $70 million in federal funding and published more than 325 peer-reviewed articles and continues as Editor in Chief, Spine. He also serves on the Board of Advanced Regenerative Medicine Institute (ARMI/BioFAB), a Department of Defense (DoD) program using stem cells and various bio-substrates to print artificial organs.
Watch Elon Musk at the WSJ CEO Council Summit talk about future plans for Tesla and SpaceX. Musk also reveals why he moved to Texas and shares his advice for business leaders.
More from the Wall Street Journal: Visit WSJ.com: http://www.wsj.com. Visit the WSJ Video Center: https://wsj.com/video.
On Facebook: https://www.facebook.com/pg/wsj/videos/ On Twitter: https://twitter.com/WSJ On Snapchat: https://on.wsj.com/2ratjSM
That is partly because AI businesses are not consumer-facing. Because they are mostly providers of back end hardware and software to other businesses, or, more critically, to governments, AI business will not become giant platform companies servicing billions of users.
Nina Xiang is the founder of China Money Network, a media platform tracking China’s venture and tech sectors.
In 10 years no one will remember the names of China’s artificial intelligence unicorns. While many aspects of the coming AI revolution remain unpredictable, one thing is clear: no AI company will emerge as a Big Tech brand.
While the internet era of the 2000s, and the mobile internet era of the 2010s, created the Chinese tech giants of today, such as Baidu, Alibaba Group Holding, and Tencent Holdings, collectively referred to as BAT, as well as Toutiao, Meituan, Didi-Chuxing, together known as TMD, the AI era is unlikely to produce anything like that by comparison — even if overly zealous investors have nursed over a dozen AI unicorns in China worth tens of billions in total.
CentOS is becoming a rolling Linux distribution, which leaves businesses depending on CentOS for a stable server or embedded operating system in the lurch.
